Imatinib is not a potent anti-SARS-CoV-2 drug.

Helong ZhaoMichelle MendenhallMichael W Deininger

Published in: Leukemia (2020)

Keyphrases

sars cov
respiratory syndrome coronavirus
chronic myeloid leukemia
anti inflammatory
adverse drug
drug induced
emergency department
coronavirus disease